FOX News: Business

Syndicate content FOX Business - Breaking news and video. Latest Current News: News, Investing, Technology, Personal Finance, Business Leaders, Travel, On Air, Small Business.
Updated: 51 sec ago

Sierra Wireless, Inc. (USA) Revels in the Growth of the Internet of Things

Thu, 04/21/2016 - 2:14pm
Image source: Sierra Wireless.
Categories: FOX News

Is Honda Moving to Take On Tesla Motors?

Thu, 04/21/2016 - 2:05pm
Honda's North America chief, John Mendel, showed off a 2017 Honda Accord Hybrid and a fuel-cell-powered Honda Clarity at an event on Thursday.
Categories: FOX News

Ouch: Qualcomm Might Finally Lose Its Clutch on the iPhone

Thu, 04/21/2016 - 2:01pm
iPhone 6s.
Categories: FOX News

ObamaCare Architect: Exchange is Not Falling Apart

Thu, 04/21/2016 - 1:52pm
Even though UnitedHealthcare (NYSE:UNH) plans to exit most Obamacare exchanges, Dr. Ezekiel Emanuel, who helped design the original Affordable Care Act plan told the FOX Business Network’s Stuart Varney while it’s important to keep big insurers, the nation’s largest health insurer has “never been a big player.”
Categories: FOX News

Netflix Stock Crashes: Buying Opportunity or Time to Panic?

Thu, 04/21/2016 - 1:50pm
Image source: Motley Fool.
Categories: FOX News

Why Las Vegas Sands Corp.'s Shares Plunged 11% Today

Thu, 04/21/2016 - 1:48pm
Image source: Las Vegas Sands.
Categories: FOX News

The 4 Most Expensive Big Bank Stocks Right Now -- and Why They Are Still Worth Buying

Thu, 04/21/2016 - 1:44pm
Image source: iStock/Thinkstock.
Categories: FOX News

Why Ericsson (ADR) Stock Plunged Today

Thu, 04/21/2016 - 1:34pm
Image source: Ericsson (ADR).
Categories: FOX News

Has American Water Works Earned a Clean Bill of Financial Health?

Thu, 04/21/2016 - 1:30pm
Born in 1996, Puddles, American Water's announcer, celebrates his 20th this year.
Categories: FOX News

Advantages of Value-Based Investing: Coming up on Friday’s Wall Street Week

Thu, 04/21/2016 - 1:25pm
For Robert Olstein, chairman and chief investment officer of Olstein Capital Management, focusing on market fundamentals will reap bigger rewards than trading on news of the day.
Categories: FOX News

Valeant Pharmaceuticals: What's the Stock Worth Now?

Thu, 04/21/2016 - 1:12pm
Valeant's intrinsic value has collapsed, but what's it worth today? Image source: PRI's Studio 360, republished under CC BY 2.0 .
Categories: FOX News

General Motors' Net Income More Than Doubles on Big Profitability Gains

Thu, 04/21/2016 - 1:05pm
U.S. sales of the new-for-2016 Chevrolet Malibu jumped 37% in the first quarter.
Categories: FOX News

3 Stocks With Better Dividends Than Frontier Communications Corporation

Thu, 04/21/2016 - 12:44pm
Frontier Communications sports a massive 7.4% dividend yield.
Categories: FOX News

3 Dividend Stocks for Retirees

Thu, 04/21/2016 - 12:41pm
Retirees who are eager to boost the income from their portfolios have been turning away from low-yielding government bonds and toward higher-yielding stocks.
Categories: FOX News

SunEdison Finally Succumbs to Bankruptcy

Thu, 04/21/2016 - 12:40pm
Image source: SunEdison.
Categories: FOX News

Why ServiceNow Inc. Shares Popped Today

Thu, 04/21/2016 - 12:33pm
What: Shares of cloud management provider ServiceNow were soaring today after a strong earnings report.
Categories: FOX News

1 Key Cenovus Energy Stock Number You Must Know

Thu, 04/21/2016 - 12:32pm
Image Source: Cenovus Energy.
Categories: FOX News

Why Mellanox Technologies Shares Got Crushed Today

Thu, 04/21/2016 - 12:30pm
Image source: Mellanox.
Categories: FOX News

Instant Analysis: McDonald's Says All-You-Can-Eat Fries Probably Not Coming to a Restaurant Near You

Thu, 04/21/2016 - 12:22pm
A McDonald's franchisee recently announced that it will open a 6,500-square-foot "McDonald's of the Future" restaurant inSt. Joseph, Missouri, in July.
Categories: FOX News

Down 41%: Is Sarepta Therapeutics Worth the Risk?

Thu, 04/21/2016 - 12:15pm
Source: Pixabay What : In what's turned into a recurring theme, shares of the clinical-stage biotech Sarepta Therapeutics are getting hammered yet again on negative regulatory news foreteplirsen, its experimental Duchenne muscular dystrophy (DMD) drug.
Categories: FOX News